HomeTNFA • NASDAQ
TNF Pharmaceuticals Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.83M | -52.49% |
Net income | -1.93M | -147.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.64M | 25.60% |
Total assets | 24.04M | 10.16% |
Total liabilities | 6.99M | 22.26% |
Total equity | 17.06M | — |
Shares outstanding | 2.76M | — |
Price to book | 0.05 | — |
Return on assets | -18.10% | — |
Return on capital | -52.22% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.93M | -147.72% |
Cash from operations | -3.63M | -15.05% |
Cash from investing | 3.09M | -8.18% |
Cash from financing | 1.20M | — |
Net change in cash | 656.33K | 220.95% |
Free cash flow | -7.52K | -100.44% |
Previous close
$0.37
Day range
$0.25 - $0.33
Year range
$0.25 - $2.16
Market cap
765.49K USD
Avg Volume
1.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
6
